Comment on CMS-2026-1255-0001

Summary: The Advanced Medical Technology Association (AdvaMed) supports the proposed rule's focus on improving interoperability and prior authorization for drugs and laboratory tests. They argue that Medicare Advantage organizations should be required to align their coverage criteria with traditional Medicare, eliminate unnecessary prior authorization for tests covered under NCDs or LCDs, and provide greater transparency regarding third-party laboratory benefit managers.